LCD L40274: MolDX: Genetic Testing for Hereditary Thrombophilia — WPS
Policy LCD-L40274 · Clinical Laboratory
WPS final LCD for hereditary thrombophilia genetic testing, eff. 10/12/2026
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code Z84.81.
Signal breakdown
4 shown · 4 total in platform
Critical
0%
High
100%
Routine
0%
Low
0%
New this month
+4
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-L40274 · Clinical Laboratory
WPS final LCD for hereditary thrombophilia genetic testing, eff. 10/12/2026
Policy LCD-L40242 · Clinical Laboratory
Noridian finalizes hereditary thrombophilia genetic test coverage 10/12/2026
Policy LCD-L40238 · Clinical Laboratory
Palmetto GBA finalizes hereditary thrombophilia genetic testing coverage Oct 202
Policy LCD-L40259 · Clinical Laboratory
CGS MolDX hereditary thrombophilia genetic testing LCD effective Oct 2026
Audit documentation
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.